# Pain Relief After Corneal Collagen Cross-Linking

> **NCT06212830** · EARLY_PHASE1 · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 51 (estimated)

## Conditions studied

- Provide Evidence-based Recommendations for Clinicians to Optimize Pain Control After CXL

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Targin
- **DRUG:** NSAID
- **DRUG:** Paracetamol

## Key facts

- **NCT ID:** NCT06212830
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2025-02
- **Final completion:** 2025-08
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2024-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06212830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06212830, "Pain Relief After Corneal Collagen Cross-Linking". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06212830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*